195 related articles for article (PubMed ID: 12691521)
21. Loss of prion protein is associated with the development of insulin resistance and obesity.
de Brito G; Lupinacci FC; Beraldo FH; Santos TG; Roffé M; Lopes MH; de Lima VC; Martins VR; Hajj GN
Biochem J; 2017 Aug; 474(17):2981-2991. PubMed ID: 28739602
[TBL] [Abstract][Full Text] [Related]
22. Dynamic transcriptional changes of TIEG1 and TIEG2 during mouse tissue development.
Jiang L; Chen Y; Chan CY; Lu G; Wang H; Li JC; Kung HF
Anat Rec (Hoboken); 2010 May; 293(5):858-64. PubMed ID: 20201061
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
[TBL] [Abstract][Full Text] [Related]
24. Cellular prion protein status in sheep: tissue-specific biochemical signatures.
Moudjou M; Frobert Y; Grassi J; La Bonnardière C
J Gen Virol; 2001 Aug; 82(Pt 8):2017-2024. PubMed ID: 11458009
[TBL] [Abstract][Full Text] [Related]
25. Expression and localization of the prion protein PrP(C) in the olfactory system of the mouse.
Le Pichon CE; Firestein S
J Comp Neurol; 2008 May; 508(3):487-99. PubMed ID: 18338400
[TBL] [Abstract][Full Text] [Related]
26. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.
Bailly Y; Haeberlé AM; Blanquet-Grossard F; Chasserot-Golaz S; Grant N; Schulze T; Bombarde G; Grassi J; Cesbron JY; Lemaire-Vieille C
J Comp Neurol; 2004 May; 473(2):244-69. PubMed ID: 15101092
[TBL] [Abstract][Full Text] [Related]
27. High levels of cellular prion protein improve astrocyte development.
Hartmann CA; Martins VR; Lima FR
FEBS Lett; 2013 Jan; 587(2):238-44. PubMed ID: 23238082
[TBL] [Abstract][Full Text] [Related]
28. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
Daude N; Marella M; Chabry J
J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373
[TBL] [Abstract][Full Text] [Related]
29. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
30. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.
Choi CJ; Anantharam V; Saetveit NJ; Houk RS; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2007 Aug; 98(2):495-509. PubMed ID: 17483122
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of prion protein gene in growth-arrested and differentiated mouse erythroleukemia and human neoplastic cells.
Gougoumas DD; Vizirianakis IS; Tsiftsoglou AS
Exp Cell Res; 2001 Apr; 264(2):408-17. PubMed ID: 11262197
[TBL] [Abstract][Full Text] [Related]
32. Identification of adjacent binding sites for the YY1 and E4BP4 transcription factors in the ovine PrP (Prion) gene promoter.
Burgess ST; Shen C; Ferguson LA; O'Neill GT; Docherty K; Hunter N; Goldmann W
J Biol Chem; 2009 Mar; 284(11):6716-24. PubMed ID: 19129193
[TBL] [Abstract][Full Text] [Related]
33. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
34. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
35. Real time PCR quantification of GFRalpha-2 alternatively spliced isoforms in murine brain and peripheral tissues.
Too HP
Brain Res Mol Brain Res; 2003 Jun; 114(2):146-53. PubMed ID: 12829325
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
[TBL] [Abstract][Full Text] [Related]
37. Prion infection of differentiated neurospheres.
Herva ME; Relaño-Ginés A; Villa A; Torres JM
J Neurosci Methods; 2010 May; 188(2):270-5. PubMed ID: 20206206
[TBL] [Abstract][Full Text] [Related]
38. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
39. Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis.
Sunyach C; Checler F
J Neurochem; 2005 Mar; 92(6):1399-407. PubMed ID: 15748158
[TBL] [Abstract][Full Text] [Related]
40. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
